Zeltiq Aesthetics Inc (ZLTQ) was Downgraded by Leerink Partners to ” Mkt Perform”. Earlier the firm had a rating of “Outperform ” on the company shares. Leerink Partners advised their Clients and Investors in a research report released on Feb 14, 2017.
On the company’s financial health, Zeltiq Aesthetics Inc reported $0.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Nov 9, 2016. Analyst had a consensus of $0.08. The company had revenue of $95.20 million for the quarter, compared to analysts expectations of $90.95 million. The company’s revenue was up 55.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.05 EPS.
Several company insiders have filed Insider transactions , on Jan 17, 2017, Mark J Foley (President and CEO) sold 10,000 shares at $41.72 per share price. According to the SEC, on Jan 5, 2017, Keith J Sullivan (CCO, President, North America) sold 8,000 shares at $44.76 per share price. On Dec 9, 2016, Carl Lamm (Vice President of Operations) sold 21,600 shares at $45.00 per share price, according to the Form-4 filing with the securities and exchange commission.
Zeltiq Aesthetics Inc opened for trading at $47.01 and hit $51.97 on the upside on Friday, eventually ending the session at $49.4, with a gain of 4.93% or 2.32 points. The heightened volatility saw the trading volume jump to 33,11,762 shares. Company has a market cap of $1,975 M.
ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.